Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Catecholamine secretory vesicle core proteins (chromogranins) contain an activity that inhibits catecholamine release, but the identity of the responsible peptide has been elusive. Size-fractionated chromogranins antagonized nicotinic cholinergic-stimulated catecholamine secretion; the inhibitor was enriched in processed chromogranin fragments, and was liberated from purified chromogranin A. Of 15 synthetic peptides spanning approximately 80% of chromogranin A, one (bovine chromogranin A344-364 [RSMRLSFRARGYGFRGPGLQL], or catestatin) was a potent, dose-dependent (IC50 approximately 200 nM), reversible secretory inhibitor on pheochromocytoma and adrenal chromaffin cells, as well as noradrenergic neurites. An antibody directed against this peptide blocked the inhibitory effect of chromogranin A proteolytic fragments on nicotinic-stimulated catecholamine secretion. This region of chromogranin A is extensively processed within chromaffin vesicles in vivo. The inhibitory effect was specific for nicotinic cholinergic stimulation of catecholamine release, and was shared by this chromogranin A region from several species. Nicotinic cationic (Na+, Ca2+) signal transduction was specifically disrupted by catestatin. Even high-dose nicotine failed to overcome the inhibition, suggesting noncompetitive nicotinic antagonism. This small domain within chromogranin A may contribute to a novel, autocrine, homeostatic (negative-feedback) mechanism controlling catecholamine release from chromaffin cells and neurons.

[1]  D. O'Connor,et al.  Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas , 1992, Neuropeptides.

[2]  D. O'Connor,et al.  Secretion of chromogranin A by peptide-producing endocrine neoplasms. , 1986, The New England journal of medicine.

[3]  K. Helle,et al.  Functional aspects of the adrenal medullary chromogranins , 1993, Neurochemistry International.

[4]  L. Kao,et al.  ATP stimulated catecholamine secretion: Response in perfused adrenal glands and a subpopulation of cultured chromaffin cells , 1995, Neuroscience Letters.

[5]  B. Livett,et al.  Noncholinergic control of adrenal catecholamine secretion. , 1993, Journal of anatomy.

[6]  H. Davidson,et al.  Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin. , 1987, The Biochemical journal.

[7]  R. Angeletti,et al.  Chromogranin A: Secretion of Processed Products from the Stimulated Retrogradely Perfused Bovine Adrenal Gland , 1993, Journal of neuroendocrinology.

[8]  D. O'Connor,et al.  Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. , 1984, The Journal of biological chemistry.

[9]  K. Klimpel,et al.  Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. , 1992, The Journal of biological chemistry.

[10]  J. Marksteiner,et al.  Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. , 1995, The Biochemical journal.

[11]  B. Conti-Tronconi,et al.  Identification of a brain acetylcholine receptor alpha subunit able to bind alpha-bungarotoxin. , 1990, The Journal of biological chemistry.

[12]  S. Muallem,et al.  The agonist-sensitive calcium pool in the pancreatic acinar cell. Activation of plasma membrane Ca2+ influx mechanism. , 1987, The Journal of biological chemistry.

[13]  B. Sharp,et al.  Nerve growth factor enhances [3H]nicotine binding to a nicotinic cholinergic receptor on PC 12 cells. , 1992, Endocrinology.

[14]  M. Claeys,et al.  Posttranslational processing of proenkephalins and chromogranins/secretogranins , 1993, Neurochemistry International.

[15]  N. Seidah,et al.  Processing of secretogranin II by prohormone convertases: Importance ofPC1 in generation of secretoneurin , 1995, FEBS letters.

[16]  L. Thim,et al.  Isolation and primary structure of a novel chromogranin A‐derived peptide, WE‐14, from a human midgut carcinoid tumour , 1992, FEBS letters.

[17]  A. D. Smith,et al.  Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation , 1967, Nature.

[18]  H. Morimoto,et al.  Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing the glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists. , 1992, Journal of Medicinal Chemistry.

[19]  D. O'Connor,et al.  Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression. , 1991, The Journal of biological chemistry.

[20]  D. O'Connor,et al.  Chromogranin A: posttranslational modifications in secretory granules. , 1991, Endocrinology.

[21]  J. Hamilton,et al.  Processing of chromogranin A by bovine parathyroid secretory granules: production and secretion of N-terminal fragments. , 1994, Endocrinology.

[22]  M. Israel,et al.  Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. , 1988, The Journal of biological chemistry.

[23]  S. Heinemann,et al.  The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[25]  J. Mallet,et al.  The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells. , 1986, The EMBO journal.

[26]  R. Fischer‐Colbrie,et al.  The chromogranins A and B: The first 25 years and future perspectives , 1992, Neuroscience.

[27]  W. Huttner,et al.  The primary structure of human chromogranin A and pancreastatin. , 1987, The Journal of biological chemistry.

[28]  D. O'Connor,et al.  Chromogranin a epitopes: Clues from synthetic peptides and peptide mapping , 1992, Neuropeptides.

[29]  G. Milligan,et al.  Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. , 1988, The Biochemical journal.

[30]  D. Aunis,et al.  Chromostatin receptors control calcium channel activity in adrenal chromaffin cells. , 1992, The Journal of biological chemistry.

[31]  D. O'Connor,et al.  Processing of chromaffin granule proteins: A profusion of proteases? , 1993, Neurochemistry International.

[32]  M. Brownstein,et al.  The sequence of porcine chromogranin A messenger RNA demonstrates chromogranin A can serve as the precursor for the biologically active hormone, pancreastatin. , 1988, Endocrinology.

[33]  N. Kirshner,et al.  22Na+ Uptake and Catecholamine Secretion by Primary Cultures of Adrenal Medulla Cells , 1982, Journal of neurochemistry.

[34]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. O'Connor,et al.  Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma. , 1984, Hypertension.

[36]  D. O'Connor,et al.  Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. , 1996, The Journal of clinical investigation.

[37]  D. O'Connor,et al.  Molecular Cloning of Chromogranin A From Rat Pheochromocytoma Cells , 1989, Hypertension.

[38]  M. Ohara-Imaizumi,et al.  Antagonism by reactive blue 2 but not by brilliant blue G of extracellular ATP‐evoked responses in PC12 phaeochromocytoma cells , 1991, British journal of pharmacology.

[39]  A. D. Smith,et al.  Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. , 1967, The Biochemical journal.

[40]  M. Grimes,et al.  Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues , 1986, Nature.

[41]  O. H. Viveros,et al.  Novel peptides from adrenomedullary chromaffin vesicles. , 1993, Journal of anatomy.

[42]  R. B. Merrifield Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[43]  D. Aunis,et al.  Secretion from chromaffin cells is controlled by chromogranin A-derived peptides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. D. Smith,et al.  Secretion from the adrenal medulla: biochemical evidence for exocytosis. , 1967, British journal of pharmacology and chemotherapy.

[45]  G. Greeley,et al.  Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. , 1993, Endocrinology.

[46]  D. Aunis,et al.  Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Aunis,et al.  Chromogranin a triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells , 1996, Neuroscience.

[48]  D. O'Connor,et al.  Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. , 1996, Hypertension.

[49]  M. Bader,et al.  Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Apps,et al.  The molecular function of adrenal chromaffin granules: Established facts and unresolved topics , 1986, Neuroscience.

[51]  M. Gratzl,et al.  Markers for neural and endocrine cells , 1991 .

[52]  L. Helman,et al.  Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway. , 1993, The Journal of clinical investigation.

[53]  K. Helle,et al.  The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels , 1992, Regulatory Peptides.

[54]  D. Aunis,et al.  Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. , 1993, European journal of biochemistry.

[55]  J. Rouse,et al.  Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. , 1991, Endocrinology.

[56]  N. Cheung,et al.  Functional Studies with Substance P Analogues: Effects of N‐Terminal, C‐Terminal, and C‐Terminus‐Extended Analogues of Substance P on Nicotine‐Induced Secretion and Desensitization in Cultured Bovine Adrenal Chromaffin Cells , 1994, Journal of neurochemistry.

[57]  A. Mithal,et al.  The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. , 1996, Endocrine reviews.

[58]  V. Mutt,et al.  Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion , 1986, Nature.

[59]  S. Arden,et al.  The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. , 1994, The Biochemical journal.

[60]  Z. Khalil,et al.  Effect of substance P on nicotine-induced desensitization of cultured bovine adrenal chromaffin cells: possible receptor subtypes , 1988, Brain Research.

[61]  M. P. Blanton,et al.  Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit. , 1994, Molecular Pharmacology.

[62]  H. Okayama,et al.  Primary structure of rat chromogranin A and distribution of its mRNA , 1988, FEBS letters.

[63]  D. Aunis,et al.  Characterization of hormone and protein release from alpha-toxin-permeabilized chromaffin cells in primary culture. , 1986, The Journal of biological chemistry.